• Rocket Science Health gets additional US patent covering its nasal delivery technology

  Rocket Science Health announced that the United States Patent and Trademark Office (USPTO) has issued US Patent No. 12,569,658, titled “Dual Nozzles For Insertion Into Paired Body Orifices (e.g., Nasal Passages, Etc.)” covering the company’s intranasal… [Read more . . .]

• Vistagen gets go-ahead for Phase 2 trial of refisolone (PH-80) nasal spray for the treatment of hot flashes

   Vistagen announced that it has received a “study may proceed” letter from the FDA in response to the company’s IND for a Phase 2 trial of refisolone nasal spray for the treatment of hot flashes caused… [Read more . . .]

• FDA extends review of Savara’s BLA for Molbreevi molgramostim inhalation solution for the treatment of aPAP

  Savara has announced that the FDA is giving itself extra time to review the company’s BLA for molgramostim inhalation solution for the treatment of autoimmune pulmonary alveolar proteinosis, setting November 22, 2026 as the new… [Read more . . .]

• ARS Pharma and ALK announce that Health Canada has approved neffy epinephrine nasal spray

  ARS Pharmaceuticals and ALK announced that Canadian regulators have approved a 2 mg dose of neffy epinephrine nasal spray for the treatment of anaphylaxis in adults and children who weigh at least 30 kg. The… [Read more . . .]

• Amneal launches generic versions of ProAir HFA albuterol MDI and QVAR beclomethasone MDI in the US

  Amneal Pharmaceuticals has announced the launch of a generic beclomethasone MDI and a generic albuterol MDI in the US, noting that these are its first metered dose inhalers in the US market. The company had… [Read more . . .]

• Iconovo names Anders Månsson as permanent CEO

• Oragenics initiates Phase 2a trial of ONP-002 neurosteroid nasal powder for mild TBI

• Nemera to offer Therakind’s DriDose intranasal dry powder nasal device

• MHRA accepts Savara’s MAA for Molbreevi molgramostim inhalation solution for the treatment of aPAP

• Glenmark takes over marketing of Ryaltris olopatadine / mometasone nasal spray in the US

More news . . .